These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16620286)

  • 1. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.
    Laleman W; Vander Elst I; Zeegers M; Servaes R; Libbrecht L; Roskams T; Fevery J; Nevens F
    Eur J Clin Invest; 2006 Apr; 36(4):242-9. PubMed ID: 16620286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
    Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronological production of thioacetamide-induced cirrhosis in the rat with no mortality.
    Norasingha A; Pradidarcheep W; Chayaburakul K
    J Med Assoc Thai; 2012 Jan; 95 Suppl 1():S173-7. PubMed ID: 23964462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.
    Matei V; Rodríguez-Vilarrupla A; Deulofeu R; García-Calderó H; Fernández M; Bosch J; Garcia-Pagán JC
    J Hepatol; 2008 Aug; 49(2):192-7. PubMed ID: 18534709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model.
    Francque S; Wamutu S; Chatterjee S; Van Marck E; Herman A; Ramon A; Jung A; Vermeulen W; De Winter B; Pelckmans P; Michielsen P
    Liver Int; 2010 Mar; 30(3):365-75. PubMed ID: 19840249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers.
    Nakata M; Nakamura K; Koda Y; Kaminou T; Ugami M; Kaneda K; Yamada R
    Hepatogastroenterology; 2002; 49(45):652-6. PubMed ID: 12063962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel canine model of portal vein stenosis plus thioacetamide administration-induced cirrhotic portal hypertension with hypersplenism.
    Lin D; Wu X; Ji X; Zhang Q; Lin Y; Chen W; Jin W; Deng L; Chen Y; Chen B; Li J
    Cell Biochem Biophys; 2012 Jan; 62(1):245-55. PubMed ID: 21904911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
    Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis.
    Marley R; Holt S; Fernando B; Harry D; Anand R; Goodier D; Davies S; Moore K
    Hepatology; 1999 May; 29(5):1358-63. PubMed ID: 10216116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats.
    Constantinou MA; Theocharis SE; Mikros E
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):11-9. PubMed ID: 17113614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in systemic and splanchnic hemodynamics after orthotopic liver transplantation in cirrhotic rats.
    Cao H; Wu Z; Zhang X; Zhang H; Chen Z; Kuang Y
    Chin Med J (Engl); 2000 Dec; 113(12):1108-11. PubMed ID: 11776147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality.
    Li X; Benjamin IS; Alexander B
    J Hepatol; 2002 Apr; 36(4):488-93. PubMed ID: 11943419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
    Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
    Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
    Hernández-Guerra M; García-Pagán JC; Turnes J; Bellot P; Deulofeu R; Abraldes JG; Bosch J
    Hepatology; 2006 Mar; 43(3):485-91. PubMed ID: 16496307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats.
    Shirin H; Aeed H; Shalev T; Sorin V; Stavinski S; Shahmurov M; Ilan Y; Avni Y
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1762-8. PubMed ID: 19120861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
    Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats.
    Hsu SJ; Lee FY; Wang SS; Hsin IF; Lin TY; Huang HC; Chang CC; Chuang CL; Ho HL; Lin HC; Lee SD
    Hepatology; 2015 May; 61(5):1672-84. PubMed ID: 25557829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
    Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.